AlphAIAlphAI — Financial news for AI agents
marketscreener.comOCT 51 min read$ALGN

Align Technology Shares Fall After Evercore ISI Downgrade

Align Technology's shares declined after Evercore ISI downgraded the stock to 'In Line' from 'Outperform' and lowered its price target to $155 from $220. The company's stock has fallen 2.78% in the past day and 9.72% over 5 days, trading at $140.60 USD.

Original reporting
marketscreener.com
Published Oct 5, 2026, 7:50 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 5, 2026, 8:09 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefMarket movers
Primary signal
$ALGN
Bearish
high confidence
Mentioned
$ALGN
Relevance
7/10
AlphAI data visualization · based on marketscreener.com
Decision brief

The 30-second read

$ALGNBearishHigh
01

Why it matters

The downgrade and PT cut suggest near‑term weakness, but longer‑term fundamentals remain solid.

02

Market read

The downgrade is the primary driver of the share decline and may influence sentiment toward similar dental device companies.

03

What to watch

Potential upcoming product launches or cost‑reduction initiatives not covered in the downgrade.

Relevance 7/10Novelty 7/10Timing: today

Background

Align Technology is a leading provider of clear aligner orthodontic solutions. The downgrade follows Evercore ISI's reassessment of its growth outlook.

Company-level read

Ticker impact

$ALGNBearishHigh confidence
Context

Evercore ISI downgraded Align Technology to In Line from Outperform and cut the price target to $155, prompting a 2% share decline.

Expected impact

downward pressure as investors price in the lower target.

Evidence & confidence

Analyst downgrade with a significant PT reduction is a fresh catalyst for a large‑cap stock.

Market effects

Sector

Dental and orthodontic device sector may see broader scrutiny as the downgrade highlights valuation concerns.

Regional

U.S. equity markets may see modest downside pressure in the healthcare equipment segment.

Global

Limited; impact confined to Align Technology and peers.

Counterpoint

What could challenge this read

Some investors may view the downgrade as an overreaction and see buying opportunity at lower levels.

Key entities

  • Analyst
    Evercore ISI

    Research firm that issued the downgrade.

Read at source← All news

StoryEvercore ISI cuts Align Technology to In Line and lowers price target

Also covered by

2 outlets

Related articles

OCT 25
$ALGNMed

Invisalign’s Moment of Truth: Will International Growth Save ALGN on Oct 28?

Align Technology (ALGN) reports Q3 earnings on Oct 28. Q2 saw record aligner shipments (+7.4% YoY) but scanner revenue fell 10.8%. International growth offset North American softness. Analysts expect Q3 revenue of $1.004B (+0.9% YoY) and EPS of $2.77 (+6.0% YoY). Management anticipates ASP declines due to pricing pressure and geographic mix. Scanner revenue is guided down 6-8% for 2026. Shares are down 1.05% YTD.

247wallst.com2 min
OCT 17
$ALGNMed

Align Technology Wins UPC Patent Case Against Angelalign

Align Technology (ALGN) won a patent case against Angelalign in the Unified Patent Court, which ruled that Angelalign's Torque Ridges feature infringes Align's European patent. The court ordered Angelalign to recall and destroy infringing products, awarded damages, and granted additional relief. The decision impacts multiple European countries and is subject to appeal. ALGN shares closed at $147.31, down 1.36%.

rttnews.com2 min
OCT 17
$ALGNHigh

A European court ordered Angelalign to stop offering some teeth-straightening trays in parts of Europe. The decision is subject to appeal.

A European court ruled that Angelalign's Torque Ridges feature infringes Align Technology's patent, ordering Angelalign to stop offering the product in parts of Europe. Align (ALGN) welcomed the decision, which includes damages and an injunction. Angelalign (6699.HK) can appeal. The ruling follows prior patent disputes between the companies.

stocktitan.net2 min
OCT 9
$ALGNHigh

Stifel cuts Align Technology stock price target on weak demand

Stifel reduced Align Technology's (ALGN) price target to $175 from $210, citing weak U.S. Invisalign demand. Shares are down 10% YTD and 19% over six months. Analysts note soft conversion and volume trends, with earnings estimates being revised downward. ALGN reported Q2 2026 earnings of $2.64 per share on $1.06B revenue, slightly beating expectations, but guidance indicated near-term pressure. Evercore ISI downgraded ALGN to In Line with a $155 target.

investing.com2 min
OCT 5
$ALGNMed

Align Technology Shares Fall After Evercore ISI Downgrades Stock

Align Technology (ALGN) shares dropped 1.7% in pre-market trading after Evercore ISI downgraded the stock to In Line from Outperform. The company reported Q2 2026 Clear Aligner revenue of $870.9M, with case shipments at 691,800, but Systems and Services revenue declined 10.8%. ALGN guided for Q3 2026 revenue of $1.0B-$1.02B and full-year growth of 3-4%. The stock has fallen 9.4% over the past month.

finance.yahoo.com2 min